Results 171 to 180 of about 14,850 (194)

Dapagliflozine

Nursing, 2021
openaire   +1 more source

Dapagliflozin

Reactions Weekly, 2017
  +4 more sources

Dapagliflozin

Reactions Weekly, 2016
  +4 more sources

Dapagliflozin

Reactions Weekly, 2020
  +4 more sources

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

Nature Medicine, 2021
Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah   +2 more
exaly  

Dapagliflozin

Reactions Weekly, 2023
  +4 more sources

Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER

Nature Medicine, 2022
Pardeep S Jhund, Toru Kondo, Jawad Haider Butt   +2 more
exaly  

Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation, 2022
Pardeep S Jhund, Rudolf A De Boer, Akshay Desai   +2 more
exaly  

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2019
Itamar Raz, Marc P Bonaca, Ofri Mosenzon
exaly   +2 more sources

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER

Circulation, 2023
Xiaowen Wang, Muthiah Vaduganathan, Brian Lee Claggett   +2 more
exaly